🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an international, multicenter, open-label study to assess the effic...
Status
Completed
Location
Study Site
Start Date
2014-03
Trial ID
NCT02093897
Treatments Being Tested
The primary objective of the study is to evaluate the effectiveness of prop...
Status
Terminated
Location
Research Site
Start Date
2015-07
Trial ID
NCT02392156
Treatments Being Tested
The purpose of this study is to assess efficacy, safety and pharmacokinetic...
Status
Completed
Location
Peking Union Medical College Hospital
Start Date
2014-06-26
Trial ID
NCT02170402
Treatments Being Tested
The primary objective of this study is to determine the pharmacokinetic pro...
Status
Completed
Location
Multiple Locations
Start Date
2005-09
Trial ID
NCT00629837
The primary purpose of this randomized, two-arm parallel clinical study in ...
Status
Completed
Location
Multiple Locations
Start Date
2006-01-04
Trial ID
NCT00243386
This study will test the well-known medicine turoctocog alfa for any side e...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2018-03-01
Trial ID
NCT03449342
Treatments Being Tested
The primary purpose of this study was to describe the time to tolerization ...
Status
Completed
Location
Center for Inherited Blood Disorders
Start Date
2017-12-08
Trial ID
NCT03093480
Treatments Being Tested
The primary purpose of this study is to describe the outcome of Immune Tole...
Status
Completed
Location
Swedish Orphan Biovitrum Research Site
Start Date
2017-08-29
Trial ID
NCT03103542
Treatments Being Tested
This study is conducted in Europe, and North and South America. The aim of ...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2014-06-05
Trial ID
NCT02035384
Treatments Being Tested
The study purpose is: * To assess the incidence of FVIII inhibitory antibo...
Status
Completed
Location
Phoenix Children's Hospital
Start Date
2014-10-31
Trial ID
NCT02210091